Fernanda P Silveira Selected Research

Valganciclovir

9/2022	Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
1/2022	Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.
11/2021	Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral Therapy.
1/2020	Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
1/2014	Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
5/2011	A polymorphism linked to elevated levels of interferon-γ is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center.
9/2010	Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernanda P Silveira Research Topics

Disease

20	Infections 01/2021 - 01/2007
9	Human Influenza (Influenza) 01/2022 - 08/2010
6	Viremia 09/2022 - 01/2014
6	Critical Illness (Critically Ill) 11/2021 - 03/2016
5	Mycoses (Diseases, Fungus) 12/2017 - 06/2007
4	COVID-19 01/2022 - 05/2021
3	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 01/2014
3	Neutropenia 09/2022 - 09/2010
3	Invasive Fungal Infections 01/2021 - 01/2010
2	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 11/2017
2	Pneumonia (Pneumonitis) 01/2022 - 08/2018
2	Sepsis (Septicemia) 10/2020 - 10/2006
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 01/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2018 - 09/2010
2	Nocardia Infections 01/2015 - 05/2007
2	Aspergillosis 05/2008 - 06/2007
1	Bacteremia 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Lymphoma (Lymphomas) 10/2019
1	West Nile Fever 01/2019
1	Frailty 01/2019
1	Dysgeusia (Parageusia) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 08/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2018
1	Fungemia 04/2017
1	Shock 04/2017
1	Surgical Wound Infection 10/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Clinical Deterioration 01/2016
1	Cryptococcosis 10/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Anemia 01/2015
1	Breakthrough Infections 01/2014
1	Septic Shock (Toxic Shock Syndrome) 12/2012
1	Multiple Organ Failure (MODS) 12/2012
1	Staphylococcal Infections 11/2012
1	Infertility (Sterility) 11/2012
1	Invasive Candidiasis 05/2012
1	Vomiting 05/2012
1	Nausea 05/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2011

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2022 - 01/2019
7	Valganciclovir FDA Link 09/2022 - 09/2010
6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2014
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2019
4	Colistin (Coly-Mycin)FDA Link 11/2017 - 03/2016
3	Foscarnet FDA LinkGeneric 09/2022 - 01/2014
3	Ganciclovir (Cytovene)FDA LinkGeneric 09/2022 - 01/2014
3	Alemtuzumab (Campath)FDA Link 05/2011 - 10/2006
2	maribavirIBA 09/2022 - 01/2019
2	SteroidsIBA 08/2018 - 05/2007
2	Immunoglobulin G (IgG)IBA 08/2018 - 06/2018
2	CreatinineIBA 01/2017 - 03/2016
2	Pharmaceutical PreparationsIBA 05/2012 - 01/2012
2	galactomannanIBA 05/2011 - 05/2008
2	Voriconazole (Vfend)FDA LinkGeneric 11/2010 - 01/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	mRNA VaccinesIBA 12/2021
1	COVID-19 VaccinesIBA 05/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	isavuconazoleIBA 10/2020
1	Vancomycin FDA LinkGeneric 10/2020
1	Micafungin (FK463)FDA Link 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	ThalliumIBA 10/2019
1	Cidofovir (Vistide)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Basiliximab FDA Link 08/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2018
1	Prednisone (Sone)FDA LinkGeneric 08/2018
1	AntigensIBA 04/2017
1	methanesulfonic acid (methanesulfonate)IBA 01/2017
1	Polymyxins (Polymyxin)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Neuraminidase (Sialidase)IBA 01/2016
1	oplunofuspIBA 01/2016
1	Oseltamivir (Tamiflu)FDA Link 01/2016
1	Zanamivir (Relenza)FDA Link 01/2016
1	Linezolid (Zyvox)FDA Link 01/2015
1	Amikacin (A.M.K)FDA LinkGeneric 01/2015
1	Methicillin (Metin)FDA Link 11/2012
1	polyglucosanIBA 05/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011

Therapy/Procedure

12	Therapeutics 09/2022 - 01/2007
10	Transplantation 11/2021 - 01/2007
10	Lung Transplantation 01/2021 - 05/2008
4	Liver Transplantation 11/2021 - 06/2007
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2017 - 01/2017
2	Artificial Respiration (Mechanical Ventilation) 04/2017 - 11/2012
2	Organ Transplantation 11/2010 - 06/2007
1	Critical Care (Surgical Intensive Care) 01/2022
1	Length of Stay 12/2021
1	Mechanical Ventilators (Ventilator) 12/2021
1	Hematopoietic Stem Cell Transplantation 12/2017
1	Cell Transplantation 01/2017